- Home
- et cancer
- Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes
5 (223) · $ 35.00 · In stock
IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
PDF) Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility
New Concepts on the Pathophysiology of Acute Coronary Syndrome
MINOCA , Myocardial Infarction with Non-Obstructive Coronary Arteries
Interplay between inflammation and thrombosis in cardiovascular pathology
Treatment algorithm for cancer patients who develop ischemia from
Mechanisms Of Myocardial Ischemia In Cancer Patients: A, 60% OFF
PDF) Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): Focus on Coronary Microvascular Dysfunction and Genetic Susceptibility
Possible origins and actions of AGF in hypertension. AGF may be
Mortality at 30 days of follow-up. Note: Patients with follow-up
